Interestingly, inhibition of the deacetylating function of HDAC6 or increasing acetylation of α-tubulin have been shown to ameliorate axonal transport deficits in models for Parkinson’s disease and Alzheimer’s disease [11, 37]. The gene discussed is HDAC6; the disease is Alzheimer disease.